These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches. Puchelle E; de Bentzmann S; Zahm JM Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436 [TBL] [Abstract][Full Text] [Related]
15. Mucus-controlling agents: past and present. King M; Rubin BK Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882 [TBL] [Abstract][Full Text] [Related]
16. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies. Hurt K; Bilton D Respiration; 2014; 88(6):441-8. PubMed ID: 25472021 [TBL] [Abstract][Full Text] [Related]
17. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action]. Kupczyk M; Kuna P Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600 [TBL] [Abstract][Full Text] [Related]
18. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance]. Miyata T Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863 [TBL] [Abstract][Full Text] [Related]
20. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4. Kater A; Henke MO; Rubin BK Ann N Y Acad Sci; 2007 Sep; 1112():140-53. PubMed ID: 17496063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]